|
Title |
Effect of autologous platelet-rich fibrin on implant stability and crestal bone levels in the maxilla - An observational study
|
|
Authors |
Shalu Sara Aby1,*, Byju Paul Kurian1, Litto Manual1, Fathima Mohamad Najeeb1, Asha Mathew2, Krishnendhu Sai1 & Sandra S Anand1
|
|
Affiliation |
1Department of Prosthodontics, Mar Baselios Dental College, Kothamangalam, Kerala, India; 2Consultant Prosthodontist, Thrikkakara Municipal Co-operative Hospital, Kakkanad, Kerala, India; *Corresponding author
|
|
|
Shalu Sara Aby - E-mail:
shalusara1019@gmail.com; Phone: +91 9620304421
|
|
Article Type |
Research Article
|
|
Date |
Received March 1, 2026; Revised March 31, 2026; Accepted March 31, 2026, Published March 31, 2026
|
|
Abstract |
Early implant stability and crestal bone preservation remain critical challenges for successful maxillary implant placement in D3 bone density, requiring effective adjunctive therapies. This study compared 30 maxillary implants across PRF-assisted and control groups, evaluating implant stability quotient (ISQ) values and crestal bone alterations over two months post-placement. The PRF group demonstrated significantly higher ISQ values and minimal crestal bone loss compared to controls (p < 0.05), indicating enhanced early osseointegration. PRF effectively supported implant primary stability while preserving surrounding bone architecture during the critical initial healing phase. These findings establish PRF as a valuable adjunctive therapy for optimizing early outcomes in challenging maxillary D3 bone conditions. |
|
Keywords |
Platelet-rich fibrin, crestal bone loss, implant stability quotient, D3 bone, dental implants
|
|
Citation |
Aby et al. Bioinformation 22(3): 1824-1827 (2026)
|
|
Edited by |
Vini Mehta
|
|
ISSN |
0973-2063
|
|
Publisher |
|
|
License |
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
|
|
|
|